Solstice Oncology
Solstice Oncology is a startup headquartered in Boston, United States, founded in 2026. It has raised at least $121.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Solstice Oncology has raised at least $121.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Solstice Oncology sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boston
- 123 See
- 7AI
- Acta Pharmaceuticals
- Acumino
- AdvocateMH
- AI Proteins
- Amplitude Vascular Systems
- Animerra
- Anna Health
- Antares Therapeutics
- Appex Group
Related
- Innovation profile of Boston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Solstice Oncology do?
Solstice Oncology is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Solstice Oncology raised?
At least $121.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Solstice Oncology based?
Solstice Oncology is headquartered in Boston, United States.
When was Solstice Oncology founded?
Solstice Oncology was founded in 2026.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.